FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2903145770> ?p ?o ?g. }

• W2903145770 endingPage "144" @default.
• W2903145770 startingPage "134" @default.
• W2903145770 abstract "Objectives To identify predictors for different treatment outcomes after prostatic artery embolization (PAE) in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Patients and Methods A post hoc analysis of data derived from the 48 patients undergoing PAE in a randomized, open‐label, non‐inferiority trial was performed. Relative changes in the International Prostate Symptoms Score (IPSS), absolute changes in maximum urinary flow rate (Q max ), and relative changes in magnetic resonance imaging‐assessed prostate volume from baseline to 12 weeks were defined as the outcomes measures of interest. Their association with various baseline characteristics and measures, technical details of PAE, and early postoperative measures were analysed using Spearman rank correlations and Wilcoxon rank‐sum tests. The most promising predictors were further evaluated in receiver‐operating characteristic (ROC) curve analyses. Results Higher total prostate and central gland (i.e. central plus transitional zone) volumes were associated with more pronounced improvements in the IPSS (Spearman rank correlation [rs]: −0.35 and −0.34; P = 0.01 and P = 0.02, respectively) and the Q max (rs: 0.31 and 0.39; P = 0.05 and P = 0.01, respectively). ROC curve analyses suggested that volumes of 39 and 38 mL for total prostate and central gland volume, respectively, would be the optimal thresholds with which to predict PAE success as measured by the IPSS. Other anatomical characteristics of the prostate, such as the central gland index, also showed an even more distinct correlation to the improvement in Q max (rs: 0.46, P = 0.003). The relative changes in prostate volume were clearly dependent on the technical performance of PAE. Occurrence of postoperative pain and blood levels of prostate‐specific antigen and C‐reactive protein emerged as potential early‐stage outcome predictors after PAE. Conclusion Baseline and peri‐operative findings might help to guide patient selection and outcome prediction for PAE. Patients with larger prostates have a higher chance of success with PAE. Larger‐scale clinical trials including a longer follow‐up are warranted to further elucidate the most suitable patients for PAE." @default.
• W2903145770 created "2018-12-11" @default.
• W2903145770 creator A5008929412 @default.
• W2903145770 creator A5022124939 @default.
• W2903145770 creator A5038040860 @default.
• W2903145770 creator A5059647166 @default.
• W2903145770 creator A5062829189 @default.
• W2903145770 creator A5066861347 @default.
• W2903145770 creator A5069666415 @default.
• W2903145770 creator A5076164795 @default.
• W2903145770 creator A5083077612 @default.
• W2903145770 creator A5091469399 @default.
• W2903145770 date "2018-12-17" @default.
• W2903145770 modified "2023-10-17" @default.
• W2903145770 title "Outcome prediction of prostatic artery embolization: <i>post hoc</i> analysis of a randomized, open‐label, non‐inferiority trial" @default.
• W2903145770 cites W1543776557 @default.
• W2903145770 cites W1887058764 @default.
• W2903145770 cites W1987068717 @default.
• W2903145770 cites W1987730025 @default.
• W2903145770 cites W2002152924 @default.
• W2903145770 cites W2002658357 @default.
• W2903145770 cites W2005179743 @default.
• W2903145770 cites W2006379044 @default.
• W2903145770 cites W2025164982 @default.
• W2903145770 cites W2034635868 @default.
• W2903145770 cites W2037008415 @default.
• W2903145770 cites W2045341260 @default.
• W2903145770 cites W2049450990 @default.
• W2903145770 cites W2050440257 @default.
• W2903145770 cites W2050675379 @default.
• W2903145770 cites W2061231638 @default.
• W2903145770 cites W2062514036 @default.
• W2903145770 cites W2065561000 @default.
• W2903145770 cites W2089765000 @default.
• W2903145770 cites W2127096827 @default.
• W2903145770 cites W2132697170 @default.
• W2903145770 cites W2151672345 @default.
• W2903145770 cites W2156170091 @default.
• W2903145770 cites W2403351495 @default.
• W2903145770 cites W2514123397 @default.
• W2903145770 cites W2555455110 @default.
• W2903145770 cites W2588574502 @default.
• W2903145770 cites W2774442252 @default.
• W2903145770 cites W2790910465 @default.
• W2903145770 cites W2794303829 @default.
• W2903145770 cites W2800908919 @default.
• W2903145770 cites W2809577318 @default.
• W2903145770 cites W2809631697 @default.
• W2903145770 cites W52004720 @default.
• W2903145770 doi "https://doi.org/10.1111/bju.14632" @default.
• W2903145770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30499637" @default.
• W2903145770 hasPublicationYear "2018" @default.
• W2903145770 type Work @default.
• W2903145770 sameAs 2903145770 @default.
• W2903145770 citedByCount "40" @default.
• W2903145770 countsByYear W29031457702019 @default.
• W2903145770 countsByYear W29031457702020 @default.
• W2903145770 countsByYear W29031457702021 @default.
• W2903145770 countsByYear W29031457702022 @default.
• W2903145770 countsByYear W29031457702023 @default.
• W2903145770 crossrefType "journal-article" @default.
• W2903145770 hasAuthorship W2903145770A5008929412 @default.
• W2903145770 hasAuthorship W2903145770A5022124939 @default.
• W2903145770 hasAuthorship W2903145770A5038040860 @default.
• W2903145770 hasAuthorship W2903145770A5059647166 @default.
• W2903145770 hasAuthorship W2903145770A5062829189 @default.
• W2903145770 hasAuthorship W2903145770A5066861347 @default.
• W2903145770 hasAuthorship W2903145770A5069666415 @default.
• W2903145770 hasAuthorship W2903145770A5076164795 @default.
• W2903145770 hasAuthorship W2903145770A5083077612 @default.
• W2903145770 hasAuthorship W2903145770A5091469399 @default.
• W2903145770 hasBestOaLocation W29031457701 @default.
• W2903145770 hasConcept C101601086 @default.
• W2903145770 hasConcept C105795698 @default.
• W2903145770 hasConcept C121608353 @default.
• W2903145770 hasConcept C126322002 @default.
• W2903145770 hasConcept C126838900 @default.
• W2903145770 hasConcept C126894567 @default.
• W2903145770 hasConcept C12868164 @default.
• W2903145770 hasConcept C143409427 @default.
• W2903145770 hasConcept C159744936 @default.
• W2903145770 hasConcept C206041023 @default.
• W2903145770 hasConcept C2776235491 @default.
• W2903145770 hasConcept C2776547966 @default.
• W2903145770 hasConcept C2779478474 @default.
• W2903145770 hasConcept C33923547 @default.
• W2903145770 hasConcept C58471807 @default.
• W2903145770 hasConcept C65409693 @default.
• W2903145770 hasConcept C67761136 @default.
• W2903145770 hasConcept C71924100 @default.
• W2903145770 hasConceptScore W2903145770C101601086 @default.
• W2903145770 hasConceptScore W2903145770C105795698 @default.
• W2903145770 hasConceptScore W2903145770C121608353 @default.
• W2903145770 hasConceptScore W2903145770C126322002 @default.
• W2903145770 hasConceptScore W2903145770C126838900 @default.
• W2903145770 hasConceptScore W2903145770C126894567 @default.
• W2903145770 hasConceptScore W2903145770C12868164 @default.
• W2903145770 hasConceptScore W2903145770C143409427 @default.

• next